Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 1, 2012, Pages 15-23

  Thompson, Susan A ^a   Burridge, Paul W ^b   Lipke, Elizabeth A ^c   Shamblott, Michael ^d   Zambidis, Elias T ^b   Tung, Leslie ^a  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c AUBURN UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmia; Cardiomyocytes; Electrophysiology; Human embryonic stem cell; Myocardial infarction

Indexed keywords

CALCEIN; CONNEXIN 43; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; SODIUM CHANNEL NAV1.5; TRANSFORMING GROWTH FACTOR BETA; TROPONIN I;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EMBRYOID BODY; EMBRYONIC STEM CELL; GENE SILENCING; HEART CONDUCTION; HEART FUNCTION; HEART MUSCLE CELL; HEART PACING; HUMAN; HUMAN CELL; IN VITRO STUDY; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REENTRY ARRHYTHMIA; REPOLARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION;

ANIMALS; ARRHYTHMIAS, CARDIAC; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINE; ELECTROPHYSIOLOGICAL PROCESSES; EMBRYONIC STEM CELLS; GENE SILENCING; HUMANS; MYOCYTES, CARDIAC; RATS; RNA, SMALL INTERFERING;

RATTUS;

EID: 84861971040     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.01.023     Document Type: Article

References (35)

1. van den Borne S.W.M., Diez J., Blankesteijn W.M., Verjans J., Hofstra L., Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 2010, 7(1):30-37.
2. Fukuda K., Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ Res 2006, 98(8):1002-1013.
3. Soejitno A., Wihandani D.M., Kuswardhani R.A. Clinical applications of stem cell therapy for regenerating the heart. Acta Med Indones 2010, 42(4):243-257.
4. Guan K., Hasenfuss G. Do stem cells in the heart truly differentiate into cardiomyocytes?. J Mol Cell Cardiol 2007, 43(4):377-387.
5. Menasche P. Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol 2011, 50(2):258-265.
6. Pekkanen-Mattila M., Chapman H., Kerkela E., Suuronen R., Skottman H., Koivisto A.-P., et al. Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype. Exp Biol Med 2010, 235(4):522-530.
7. Zeevi-Levin N., Fau-Itskovitz-Eldor J., Itskovitz-Eldor J., Fau-Binah O., Binah O. Functional properties of human embryonic stem cell-derived cardiomyocytes. Crit Rev Eukaryot Gene Expr 2010, 20(1):51-59.
8. Zhu W.Z., Santana L.F., Laflamme M.A. Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes. PLoS One 2009, 4(4):e5407.
9. Caspi O., Huber I., Kehat I., Habib M., Arbel G., Gepstein A., et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 2007, 50(19):1884-1893.
10. Dai W., Field L.J., Rubart M., Reuter S., Hale S.L., Zweigerdt R., et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol 2007, 43(4):504-516.
11. van Laake L.W., Passier R., Doevendans P.A., Mummery C.L. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 2008, 102(9):1008-1010.
12. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007, 25(9):1015-1024.
13. Leor J., Gerecht S., Cohen S., Miller L., Holbova R., Ziskind A., et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 2007, 93(10):1278-1284.
14. Thompson S.A., Copeland C.R., Reich D.H., Tung L. Mechanical coupling between myofibroblasts and cardiomyocytes slows electric conduction in fibrotic cell monolayers. Circulation 2011, 123(19):2083-2093.
15. Burridge P.W., Thompson S., Millrod M.A., Weinberg S., Yuan X., Peters A., et al. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One 2011, 6(4):e18293.
16. Tung L., Bursac N., Aguel F. Rotors and spiral waves in two dimensions. Cardiac electrophysiology - from cell to bedside 2004, 336-344. W. B. Saunders, Philadelphia, PA. D.P. Zipes, J. Jalife (Eds.).
17. Tomescot A., Leschik J., Bellamy V., Dubois G., Messas E., Bruneval P., et al. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells 2007, 25(9):2200-2205.
18. Wit A.L., Janse M.J. Experimental models of ventricular tachycardia and fibrillation caused by ischemia and infarction. Circulation 1992, 85(1):I32-I42.
19. Pamintuan J.C., Dreifus L.S., Watanabe Y. Comparative mechanisms of antiarrhythmic agents. Am J Cardiol 1970, 26(5):512-519.
20. Rossman E.I., Liu K., Morgan G.A., Swillo R.E., Krueger J.A., Gardell S.J., et al. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model. J Pharmacol Exp Ther 2009, 329(3):1127-1133.
21. Sartiani L., Bettiol E., Stillitano F., Mugelli A., Cerbai E., Jaconi M.E. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 2007, 25(5):1136-1144.
22. Satin J., Kehat I., Caspi O., Huber I., Arbel G., Itzhaki I., et al. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol 2004, 559(2):479-496.
23. Kehat I., Gepstein A., Spira A., Itskovitz-Eldor J., Gepstein L. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ Res 2002, 91(8):659-661.
24. Kehat I., Khimovich L., Caspi O., Gepstein A., Shofti R., Arbel G., et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004, 22(10):1282-1289.
25. Xue T., Cho H.C., Akar F.G., Tsang S.-Y., Jones S.P., Marban E., et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005, 111(1):11-20.
26. Lau D.H., Clausen C., Sosunov E.A., Shlapakova I.N., Anyukhovsky E.P., Danilo P., et al. Epicardial border zone overexpression of skeletal muscle sodium channel SkM1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia: an in silico, in vivo, in vitro study. Circulation 2009, 119(1):19-27.
27. Williams J.A. Origin of transmembrane potentials in non-excitable cells. J Theor Biol 1970, 28(2):287-296.
28. Roell W., Lewalter T., Sasse P., Tallini Y.N., Choi B.-R., Breitbach M., et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007, 450(7171):819-824.
29. Laflamme M.A., Gold J., Xu C., Hassanipour M., Rosler E., Police S., et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 2005, 167(3):663-671.
30. Hayashi H., Terada H., McDonald T. Arrhythmia and electrical heterogeneity during prolonged hypoxia in guinea pig papillary muscles. Can J Physiol Pharmacol 1997, 75(1):44-51.
31. Dobmeyer D.J., Stine R.A., Leier C.V., Greenberg R., Schaal S.F. The arrhythmogenic effects of caffeine in human beings. N Engl J Med 1983, 308(14):814-816.
32. Liao S.-Y., Liu Y., Siu C.-W., Zhang Y., Lai W.-H., Au K.-W., et al. Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Heart Rhythm 2010, 7(12):1852-1859.
33. Laflamme M.A., Murry C.E. Regenerating the heart. Nat Biotechnol 2005, 23(7):845-856.
34. Oettgen P. Cardiac stem cell therapy. Circulation 2006, 114(4):353-358.
35. Tung L., Thompson S. Advantages and pitfalls of cell cultures as model systems to study cardiac mechanoelectric coupling. Cardiac mechano-electric coupling and arrhythmias 2011, 143-150. Oxford University Press, Oxford, U.K. P. Kohl, F. Sachs, M.R. Franz (Eds.).